<?xml version='1.0' encoding='utf-8'?>
<document id="20029444"><sentence text="Interaction between capecitabine and brivudin in a patient with breast cancer."><entity charOffset="20-32" id="DDI-PubMed.20029444.s1.e0" text="capecitabine" /><entity charOffset="37-45" id="DDI-PubMed.20029444.s1.e1" text="brivudin" /><pair ddi="false" e1="DDI-PubMed.20029444.s1.e0" e2="DDI-PubMed.20029444.s1.e0" /><pair ddi="false" e1="DDI-PubMed.20029444.s1.e0" e2="DDI-PubMed.20029444.s1.e1" /></sentence><sentence text="A 66-year-old woman with metastatic mammary carcinoma, who was being treated with capecitabine, contracted a herpes zoster infection that was treated with the antiviral drug brivudin"><entity charOffset="82-94" id="DDI-PubMed.20029444.s2.e0" text="capecitabine" /></sentence><sentence text=" A drug-drug interaction between brivudin and capecitabine caused medullar aplasia, serious toxic effects to the intestinal mucous membrane, hand-foot syndrome, onycholysis and dental pigmentation"><entity charOffset="46-58" id="DDI-PubMed.20029444.s3.e0" text="capecitabine" /></sentence><sentence text="" /><sentence text="Physical examination, blood analysis, blood cultures, chest X-ray, bone marrow aspiration and biopsy" /><sentence text="" /><sentence text="Serious adverse event secondary to inhibition of dihydropyrimidine dehydrogenase by a drug-drug interaction between capecitabine and brivudin"><entity charOffset="49-66" id="DDI-PubMed.20029444.s7.e0" text="dihydropyrimidine" /><entity charOffset="116-128" id="DDI-PubMed.20029444.s7.e1" text="capecitabine" /><entity charOffset="133-141" id="DDI-PubMed.20029444.s7.e2" text="brivudin" /><pair ddi="false" e1="DDI-PubMed.20029444.s7.e0" e2="DDI-PubMed.20029444.s7.e0" /><pair ddi="false" e1="DDI-PubMed.20029444.s7.e0" e2="DDI-PubMed.20029444.s7.e1" /><pair ddi="false" e1="DDI-PubMed.20029444.s7.e0" e2="DDI-PubMed.20029444.s7.e2" /><pair ddi="false" e1="DDI-PubMed.20029444.s7.e1" e2="DDI-PubMed.20029444.s7.e1" /><pair ddi="false" e1="DDI-PubMed.20029444.s7.e1" e2="DDI-PubMed.20029444.s7.e2" /></sentence><sentence text="" /><sentence text="Intravenous hydration, imipenem, red blood cell and platelet transfusions, filgrastim, omeprazole, care of the mouth and feet, topical anesthetics, systemic analgesics and parenteral nutrition"><entity charOffset="23-31" id="DDI-PubMed.20029444.s9.e0" text="imipenem" /><entity charOffset="87-97" id="DDI-PubMed.20029444.s9.e1" text="omeprazole" /><pair ddi="false" e1="DDI-PubMed.20029444.s9.e0" e2="DDI-PubMed.20029444.s9.e0" /><pair ddi="false" e1="DDI-PubMed.20029444.s9.e0" e2="DDI-PubMed.20029444.s9.e1" /></sentence><sentence text="" /></document>